Skip to main content
. 2017 Sep 30;34(3):226–235. doi: 10.36141/svdld.v34i3.5214

Table 1.

Patient Characteristics (n = 52)

Median (interquartile range) or number (%)
Age, y 73.0, (66.3-76.8)
Gender, male 44 (84.6%)
Smoking History 47 (90.4%)
BAL, performed 22 (42.3%)
SLB confirmation 7 (13.5%)
CPFE 17 (32.7%)
%FVC, % 86.5, (71.9-99.9)
%Dlco, % 39.7, (33.0-50.0)
6MWD, m 491, (416-529)
Minimum SpO2 during 6MWT, % 86.0, (80.5-89.3)
PaO2 on room air, Torr 83.1, (75.7-91.5)
KL-6, U/mL 784, (625-1190)
SP-D, ng/mL 232, (176-232)
mMRC (0 to 4) 1, (0-2)
HADS (0 to 21)
Anxiety 3, (1-5)
Depression 4, (2-7)
PSQI (0 to 21) 4, (2-8)

Abbreviations: IPF, idiopathic pulmonary fibrosis; BAL, bron- choalveolar lavage; SLB, surgical lung biopsy; CPFE, combined pulmonary fibrosis and emphysema; %FVC, percentage of the predicted forced vital capacity; %DLCO, percentage of the predicted diffusing capacity of the lung for carbon monoxide; 6MWD, six- minute walk distance; SpO2, oxygen saturation measured by pulse oximetry; 6MWT, six-minute walk test; PaO2 partial pressure of arterial oxygen; KL-6, Krebs von den lungen-6; SP-D, surfactant protein-D; mMRC, modified Medical Research Council; HADS, Hospital Anxiety and Depression Scale; PSQI, Pittsburgh Sleep Quality Index.